[1]
J. P. Remédio Marques, “Compulsory licensing of patent rights on grounds of public interest and the SARS-CoV-2 pandemic: considerations de lege lata and de lege ferenda”, PIDCC, vol. 11, no. 1, pp. 27–52, Jan. 2022, doi: 10.16928/2316-8080.jan2022_03.